bioRxivMicrobiologyPreprint
SARS-CoV-2 infection damages airway motile cilia and impairs mucociliary clearance
R. Robinot, M. Hubert, G. Dias de Melo, F. Lazarini, T. Bruel, N. Smith, S. Levallois, F. Larrous, J. Fernandes, S. Gellenoncourt, S. Rigaud, O. Gorgette, C. Thouvenot, C. Trebeau, G. Dumenil, A. Mallet, S. Gobaa, R. Etournay, P.-M. Lledo, M. Lecuit, H. Bourhy, D. Duffy, V. Michel, O. Schwartz, L. A. Chakrabarti
Abstract
Understanding how SARS-CoV-2 spreads within the respiratory tract is important to define the parameters controlling the severity of COVID-19. We examined the functional and structural consequences of SARS-CoV-2 infection in a reconstituted human bronchial epithelium model. SARS-CoV-2 replication caused a transient decrease in epithelial barrier function and disruption of tight junctions, though viral particle crossing remained limited. Rather, SARS-CoV-2 replication led to a rapid loss of the ciliary layer, characterized at the ultrastructural level by axoneme loss and misorientation of remaining basal bodies. The motile cilia function was compromised, as measured in a mucociliary clearance assay. Epithelial defense mechanisms, including basal cell mobilization and interferon-lambda induction, ramped up only after the initiation of cilia damage. Analysis of SARS-CoV-2 infection in Syrian hamsters further demonstrated the loss of motile cilia in vivo. This study identifies cilia damage as a pathogenic mechanism that could facilitate SARS-CoV-2 spread to the deeper lung parenchyma.
- organism: human
- organism: mouse
- assay: spatial transcriptomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mucociliary Transport Deficiency and Disease Progression in Syrian Hamsters with SARS-CoV-2 Infection
Q. Li, K. Vijaykumar, … S. M. Rowe·bioRxiv·Jan 16, 2022
- Mucociliary Clearance Augmenting Drugs Block SARS-Cov-2 Replication in Human Airway Epithelial Cells
J. Campos-Gomez, C. Fernandez Petty, … S. M. Rowe·bioRxiv·Jan 30, 2023
- SARS-CoV-2 causes severe alveolar inflammation and barrier dysfunction
S. Deinhardt-Emmer, S. Böttcher, … C. Ehrhardt·bioRxiv·Aug 31, 2020
- SARS-CoV-2 leverages airway epithelial protective mechanism for viral infection
Allison Marie Greaney, Micha Sam Brickman Raredon, … Andre Levchenko·iSciencePeer-reviewed·Feb 10, 2023
- COVID-19 Causes Ciliary Dysfunction as Demonstrated by Human Intranasal Micro-Optical Coherence Tomography Imaging
K. Vijaykumar, H. M. Leung, … S. M. Rowe·bioRxiv·Jul 8, 2022
- Neutrophil-epithelial interactions augment infectivity and pro-inflammatory responses to SARS-CoV-2 infection
B. A. Calvert, E. J. Quiroz, … A. L. Ryan·bioRxiv·Aug 9, 2021